Literature DB >> 11535504

Catheter-related deep venous thrombosis in children with hemophilia.

J M Journeycake1, C T Quinn, K L Miller, J L Zajac, G R Buchanan.   

Abstract

Central venous catheters (CVCs) are a common adjunct to hemophilia therapy, but the risk of CVC-related deep venous thrombosis (DVT) in hemophiliacs is not well defined. In a previous study, 13 patients with CVCs had no radiographic evidence of DVT. However, recent abstracts and case studies demonstrate that DVT does occur. Therefore, this study sought to determine the frequency of DVT in children with hemophilia and long-term CVCs and to correlate venographic findings with clinical features. All hemophilia patients with tunneled subclavian CVCs in place for 12 months or more were candidates for evaluation. Patients were examined for physical signs of DVT and questioned about catheter dysfunction. Contrast venograms were obtained to identify DVT. Fifteen boys with severe hemophilia were evaluated, including 9 from the initially studied group of 13. Eight patients had evidence of DVT, 5 of whom previously had normal venograms. Five of 15 patients had clinical problems related to the CVC, all of whom had DVT. Four of 15 patients had suggestive physical signs; 3 had DVT. The mean duration of catheter placement for all patients was 57.5 months (range, 12-102 months). For patients with DVT, the mean duration was 66.6 +/- 7.5 months, compared to 49.5 +/- 7.2 months for patients without DVT (P =.06). No patient whose CVC was in place fewer than 48 months had an abnormal venogram. Many hemophilia patients with CVCs develop DVT of the upper venous system, and the risk increases with duration of catheter placement.

Entities:  

Mesh:

Year:  2001        PMID: 11535504     DOI: 10.1182/blood.v98.6.1727

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  Barriers to primary prophylaxis in haemophilic children: the issue of the venous access.

Authors:  Elena Santagostino; Maria Elisa Mancuso
Journal:  Blood Transfus       Date:  2008-09       Impact factor: 3.443

Review 2.  Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors.

Authors:  Neil A Goldenberg; Marco P Donadini; Susan R Kahn; Mark Crowther; Gili Kenet; Ulrike Nowak-Göttl; Marilyn J Manco-Johnson
Journal:  Haematologica       Date:  2010-06-30       Impact factor: 9.941

3.  Epidemiology and outcomes of clinically unsuspected venous thromboembolism in children: A systematic review.

Authors:  Anjali A Sharathkumar; Tina Biss; Ketan Kulkarni; Sanjay Ahuja; Matt Regan; Christoph Male; Shoshana Revel-Vilk
Journal:  J Thromb Haemost       Date:  2020-04-15       Impact factor: 5.824

4.  Deep venous thrombosis screening in patients with inherited bleeding disorders and central venous catheters.

Authors:  C R Cost; J M Journeycake
Journal:  Haemophilia       Date:  2011-03-24       Impact factor: 4.287

5.  Long-term results of central venous access devices in children with haemophilia.

Authors:  Manasvi Upadhyaya; Michael Richards; Sarah Buckham; B R Squire
Journal:  Pediatr Surg Int       Date:  2009-05-20       Impact factor: 1.827

6.  Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children. Results of a phase 3 trial.

Authors:  Gili Kenet; Hervé Chambost; Christoph Male; Thierry Lambert; Susan Halimeh; Tatiana Chernova; Maria Elisa Mancuso; Julie Curtin; Christine Voigt; Yanyan Li; Iris Jacobs; Elena Santagostino
Journal:  Thromb Haemost       Date:  2016-09-01       Impact factor: 5.249

Review 7.  The Impact of Central Venous Catheters on Pediatric Venous Thromboembolism.

Authors:  Julie Jaffray; Mary Bauman; Patti Massicotte
Journal:  Front Pediatr       Date:  2017-01-23       Impact factor: 3.418

Review 8.  Venous Thromboembolism in Children with Cancer and Blood Disorders.

Authors:  Richard H Ko; Courtney D Thornburg
Journal:  Front Pediatr       Date:  2017-02-06       Impact factor: 3.418

Review 9.  Non-factor therapies for bleeding disorders: A primer for the general haematologist.

Authors:  Dawn Swan; Johnny Mahlangu; Jecko Thachil
Journal:  EJHaem       Date:  2022-04-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.